Back grey_arrow_rt.gif
 
Archived NATAP Articles from December 2002
 
null.gif
 
 
  1. Prevalence of Hepatitis C Virus Infection Among Clients of HIV Counseling and Testing Sites --- Connecticut, 1999. - Source CDC - (12/30/02)

    2.  
  2. PDF FORMAT - The Challenge of Developing a Vaccine against Hepatitis C Virus - (12/27/02)

    3.  
  3. BRISTOL-MYERS SQUIBB SUBMITS NEW DRUG APPLICATION FOR INVESTIGATIONAL PROTEASE INHIBITIOR ATAZANAVIR FOR TREATMENT OF HIV INFECTION - (12/27/02)

    4.  
  4. Press Release From Vertex - Vertex Pharmaceuticals Announces Submission of NDA/MAA Filings in U.S. and Europe for GW433908 (new formulation of Agenerase [amprenavir]) for Treatment of HIV Infection - (12/27/02)

    5.  
  5. Subclinical impairment of brain function in chronic hepatitis C infection - (12/27/02)

    6.  
  6. VA Offers New Treatment for Veterans with Hepatitis C - (12/27/02)

    7.  
  7. High Rates of HCV, HIV/HCV Coinfection, and Alcohol Abuse in NYC Veterans - (12/27/02)

    8.  
  8. Contact Vaccinia Transmission of Vaccinia From Smallpox Vaccination - JAMA, Journal of the American Medical Association. Vol. 288 No. 15, October 16, 2002 John M. Neff, MD; J. Michael Lane, MD, MPH; Vincent A. Fulginiti, MD; Donald A. Henderson, MD, MPH - (12/27/02)

    9.  
  9. Is Mass Smallpox Vaccination The Best Choice? commentaries in the New England Journal of Medicine - (12/27/02)

    10.  
  10. Update on the Manufacture of Investigational HIV Drug FUZEON Press Release From Roche - (12/19/02)

    11.  
  11. Prevalence of Hepatitis C Virus Infection and Risk for Hepatocellular Carcinoma and Non-Hodgkin Lymphoma in AIDS - (12/19/02)

    12.  
  12. Part of AIDS Virus Can Hide Itself Mark Evans, Associated Press Writer; December 16, 2002 - (12/19/02)

    13.  
  13. Emergence of drug-resistant HIV-1 variants in patients undergoing structured treatment interruptions - (12/19/02)

    14.  
  14. Changes in Plasma Human Immunodeficiency Virus Type 1 RNA Associated with Herpes Simplex Virus Reactivation and Suppression - (12/19/02)

    15.  
  15. Risk of HIV infection attributable to oral sex among men who have sex with men and in the population of men who have sex with men - (12/19/02)

    16.  
  16. An open-label study of tenofovir in HIV-1 and Hepatitis B virus co-infected individuals - (12/16/02)

    17.  
  17. Osteonecrosis in HIV disease: epidemiology, etiologies, and clinical management - (12/16/02)

    18.  
  18. HIV, HAART and Older Patients - (12/16/02)

    19.  
  19. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS) - (12/16/02)

    20.  
  20. Tenofovir Resistance in Treatment-Naive Individuals, FDA Approval Report from 6th Glasgow Conference on HIV - Written for NATAP by Graeme Moyle, MD, Chelsea & Westminster Hospital, London, UK and Jules Levin - (12/13/02)

    21.  
  21. Does HCV Replicate Outside The Liver and It's Significance? - (12/12/02)

    22.  
  22. Does Bleach Disinfection of Syringes Protect Against Hepatitis C Infection Among Young Adult Injection Drug Users? - (12/12/02)

    23.  
  23. The Hepatitis D Virus - (12/06/02)

    24.  
  24. Lamivudine for Chronic Delta Hepatitis - (12/06/02)

    25.  
  25. Protease inhibitors and cardiovascular outcomes in patients with HIV-1 - (12/05/02)

    26.  
  26. Jocelyn Elders Speaks Out On Harm Reduction & Clean Needles: an answer to stemming tide of HIV and HCV - (12/05/02)

    27.  
  27. 6th Intl Congress on Drug Therapy in HIV - Written by Graeme Moyle, MD, Chelsea & Westminster Hospital, London, UK - (12/5/02)

    28.  
  28. FDA Approves Pegasys in Combination With Copegus (ribavirin) for HCV Treatment Press Release from Roche - (12/04/02)

    29.  
  29. PDF FORMAT - NATIONAL INSTITUTES OF HEALTH CONSENSUS DEVELOPMENT CONFERENCE FINAL STATEMENT Management of Hepatitis C:2002; June 10 -12,2002 - (12/02/02)

    30.  
  30. PDF FORMAT - Management of Metabolic Complications Associated With Antiretroviral Therapy for HIV-1 Infection: Recommendations of an International AIDS Society-USA Panel - (12/02/02)

    31.  
  31. 6th Intl Congress - Report from 6th Intl Congress on Drug Therapy in HIV-Infection Reported by Mike Youle, MD, Royal Free Hospital, London, UK - (12/2/02)

    32.  
  32. F.D.A. Approves New Osteoporosis Therapy, a Bone-Growing Drug By THE ASSOCIATED PRESS - (12/02/02)

    33.  
  33. 6th Intl Congress - TDM (Therapeutic Drug Monitoring) - (12/2/02)

    34.  
  34. Increased fat accumulation in the liver in HIV-infected patients with antiretroviral therapy-associated lipodystrophy - (12/02/02)

    35.  
  35. A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women - (12/02/02)

    36.  
  36. Jocelyn Elders Speaks Out On Harm Reduction & Clean Needles: an answer to stemming tide of HIV and HCV - (12/05/02)

    37.